These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effect of topical drugs on mouse ear epidermal transglutaminase activity. De Young L; Ballaron S J Invest Dermatol; 1982 Sep; 79(3):189-93. PubMed ID: 6125546 [TBL] [Abstract][Full Text] [Related]
5. Alteration of human epidermal transglutaminase during its activation. Negi M; Park JK; Ogawa H J Dermatol Sci; 1990 May; 1(3):167-71. PubMed ID: 1982221 [TBL] [Abstract][Full Text] [Related]
6. ATP activation of protein degradation by extracts of crude and purified lysosomal preparations. Pillai S; Zull JE Biochim Biophys Acta; 1985 Nov; 843(1-2):92-100. PubMed ID: 3851674 [TBL] [Abstract][Full Text] [Related]
8. Release of acid phosphatase from lysosomal membranes by cathepsin D. Tanaka Y; Himeno M; Kato K J Biochem; 1990 Aug; 108(2):287-91. PubMed ID: 2121727 [TBL] [Abstract][Full Text] [Related]
9. New findings on epidermal transglutaminase substrates. Buxman MM; Lobitz CJ Curr Probl Dermatol; 1980; 10():245-54. PubMed ID: 6113099 [TBL] [Abstract][Full Text] [Related]
10. Differentiation markers in fetal epidermis: transglutaminase and transpeptidase. Buxman MM; Kocarnik MJ; Holbrook KA J Invest Dermatol; 1979 Apr; 72(4):171-7. PubMed ID: 34661 [TBL] [Abstract][Full Text] [Related]
11. Possible activation mechanisms of transglutaminase in epidermis. Negi M; Matsui T; Ogawa H Arch Dermatol Res; 1981; 271(1):101-5. PubMed ID: 6117258 [No Abstract] [Full Text] [Related]
12. [Activation mechanisms of epidermal transglutaminase, the cross-linking enzyme (author's transl)]. Negi M; Matsui T; Ogawa H Nihon Hifuka Gakkai Zasshi; 1980; 90(6):531-3. PubMed ID: 6106080 [No Abstract] [Full Text] [Related]
13. Purification and immunohistochemical localization of aspartic proteinases in rat epidermis. Hara K; Fukuyama K; Sakai H; Yamamoto K; Epstein WL J Invest Dermatol; 1993 Apr; 100(4):394-9. PubMed ID: 8454902 [TBL] [Abstract][Full Text] [Related]
14. Lysosomal digestion of thyroglobulin: role of cathepsin D and thiol proteases. Yoshinari M; Taurog A Endocrinology; 1985 Oct; 117(4):1621-31. PubMed ID: 3896765 [TBL] [Abstract][Full Text] [Related]
15. Linkage between phosphorylated cystatin alpha and filaggrin by epidermal transglutaminase as a model of cornified envelope and inhibition of cathepsin L activity by cornified envelope and the conjugated cystatin alpha. Takahashi M; Tezuka T; Kakegawa H; Katunuma N FEBS Lett; 1994 Mar; 340(3):173-6. PubMed ID: 7907550 [TBL] [Abstract][Full Text] [Related]
16. Human epidermal transglutaminase. II. Immunologic properties. Ogawa H; Goldsmith LA J Invest Dermatol; 1977 Jan; 68(1):32-5. PubMed ID: 12234 [TBL] [Abstract][Full Text] [Related]
17. Lysosomal enzyme secretion into pancreatic juice in rats injected with pancreatic secretagogues and augmented secretion after short-term pancreatic duct obstruction. Hirano T Nihon Geka Hokan; 1994 Jan; 63(1):21-35. PubMed ID: 7529987 [TBL] [Abstract][Full Text] [Related]
18. Keratin cross-linking and epidermal transglutaminase. A review with observations on the histochemical and immunochemical localization of the enzyme. Buxman MM; Wuepper KD J Invest Dermatol; 1975 Jul; 65(1):107-12. PubMed ID: 239069 [TBL] [Abstract][Full Text] [Related]
19. Role of thiols, pH and cathepsin D in the lysosomal catabolism of serum albumin. Mego JL Biochem J; 1984 Mar; 218(3):775-83. PubMed ID: 6721834 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of 12-O-tetradecanoylphorbol-13-acetate induction of epidermal transglutaminase activity by protease inhibitors. Kawamura H; Strickland JE; Yuspa SH Cancer Res; 1983 Sep; 43(9):4073-7. PubMed ID: 6135503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]